from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3173c/-

LFCtreatmentdescriptionclass of inhibitor

-0.568

Amikacinug/mL Amikacintranslation

-0.549

Cap5-10ug/mL Capreomycintranslation

-0.567

Rox10-50 ug/mL Roxithromycintranslation

0.308

SM2-5 ug/mL Streptomycintranslation

0.328

Tet5-10 ug/mL Tetracyclinetranslation

-1.057

Rif0.2-5ug/mL Rifampicintranscription

-0.471

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.699

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.036

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.078

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.356

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.435

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.751

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.393

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.485

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.514

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.328

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.262

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.632

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.394

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.571

KCN5-20 ug/mL Potassium cyaniderespiration

0.253

NaN30.2-2 mM Sodium aziderespiration

1.167

Nigericin50 uM Nigericinrespiration

0.620

TRC10-150 ug/mL Triclosanrespiration

0.631

TRZ10-25 ug/mL Thioridazinerespiration

1.294

Valinomycin0.5-10 uM Valinomycinrespiration

-0.833

ZnSO42 mM ZnSO4respiration

1.449

menadione6-10 ug/mL Menadionerespiration

-0.707

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.575

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.841

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.544

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.601

NRP_1Non-replicating persistence stage 1dosRassociated

-0.357

Amp0.2mg/mL AmpicillincellWall

-0.311

Cephalexin20-100 ug/mL CephalexincellWall

-0.850

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.363

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.044

EMB10-20 ug/mL EthambutolcellWall

-0.575

Eta12-40 ug/mL EthionamidecellWall

-0.537

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.415

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.855

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.642

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.690

BZA0.12 mg/mL BenzamidearomaticAmides

1.277

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.500

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.451

H2O24 mM hydrogen peroxideDNAdamaging

-0.572

Levo10 ug/mL LevofloxacinDNAdamaging

-0.376

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.533

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.471

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.421

UVUV-irradiationDNAdamaging

0.630

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.907

Antimycin12.5-50 ug/mL Antimycin A?

-0.728

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.390

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.411

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.248

PA8240.2-2 ug/mL PA-824?

1.344

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.277

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.660

Verapamil50 uM Verapamil?

-0.435

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.117

methoxatin10-20 ug/mL Methoxatin?